Multimodal Treatment of Colorectal Cancer Liver Metastases Dr. Efraim Idelevich MD, Ph. D, Gastrointestinal Oncology Unit Kaplan Medical Center Rehovot Israel June 2011
COLORECTAL CANCER Worldwide incidence* Western Europe Male Female 39. 8 29. 0 Eastern Europe Male Female 25. 3 18. 5 Japan Male Female 39. 5 24. 6 Australia/ Male New Zealand Female 45. 8 34. 8 South Central Male Asia Female 5. 0 3. 8 Northern Africa Male Female 44. 1 31. 0 6. 0 4. 2 Southern Africa Israel Male Female 11. 2 8. 5 Central America Male Female 8. 8 7. 9 North America Male Female 44. 3 32. 8 *Incidence per 100, 000 population. Parkin DM, et al. CA Cancer J Clin. 1999; 49: 33 -64.
COLORECTAL CANCER 1930 -1997 Age-adjusted death rate*, male, USA Rate per 100, 000 Male Population 80 Prostate Lung & Bronchus Colon & Rectum 70 60 Estimated incidence (% of all cancers in men): Prostate=31%; Lung & Bronchus=14%; Colon and rectum=10% 50 40 30 20 10 0 1930 1940 1950 1960 1970 1980 1997 Year *Adjusted to the age distribution of the 1970 census population. Greenlee RT, et al. CA Cancer J Clin. 2001; 51: 15 -36.
COLORECTAL CANCER 1930 -1997 Age-adjusted death rate*, female, USA Rate per 100, 000 Female Population 80 Breast Lung & Bronchus Colon & Rectum 70 Estimated 2001 incidence (% of all cancers in women): Breast=31%; Lung=13%; Colon and rectum=11% 60 50 40 30 20 10 0 1930 1940 1950 1960 1970 1980 1997 Year *Adjusted to the age distribution of the 1970 census population. Greenlee RT, et al. CA Cancer J Clin. 2001; 51: 15 -36.
COLORECTAL CANCER Disease Stage at Time of Diagnosis Stage I 15% Stage II 20%– 30% Stage III 30%– 40% Stage IV 20%– 25% Hamilton IM, Grem JL. Current Cancer Therapeutics. 3 rd ed. 1998; 157.
Polyp Carcinoma EGF Abnormal production of cytokines Angiogenic switch Mutations in growth control genes Mutations in apoptosis control genes Metastatic carcinoma
Stage IV Colon Cancer Group I Curable disease Group II ! Group III Group IV Potentially curable disease Symptomatic non curable disease Asymptomatic non curable disease Non curable
EORTC, ASCO 2007